phenazepam has been researched along with Drug Withdrawal Symptoms in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Agibalova, TV; Aguzarov, AD; Antonenko, AР; Barna, IV; Bryun, EA; Duzhev, DV; Galaktionova, TE; Grishina, EA; Orlova, AV; Rozochkin, IN; Savchenko, LM; Skryabin, VY; Sorokin, AS; Sychev, DA; Zastrozhin, MS | 1 |
Avdeeva, TI; Ivanets, NN; Kinkulkina, MA; Tikhonova, YG | 1 |
Gudasheva, TA; Kadnikov, IA; Kolik, LG; Seredenin, SB; Zhukov, VN | 1 |
Garibova, TL; Voronina, TA | 2 |
Burov, IuV; Viglinskaia, IV | 1 |
6 other study(ies) available for phenazepam and Drug Withdrawal Symptoms
Article | Year |
---|---|
Using a personalized clinical decision support system for bromdihydrochlorphenylbenzodiazepine dosing in patients with anxiety disorders based on the pharmacogenomic markers.
Topics: Adult; Alcoholism; Anxiety Disorders; Benzodiazepines; Cytochrome P-450 CYP2C19; Decision Support Systems, Clinical; GABA Agents; Humans; Male; Middle Aged; Pharmacogenetics; Polymorphism, Single Nucleotide; Substance Withdrawal Syndrome | 2018 |
[Remote consequences of the long-term uncontrollable consumption of anxiolytics and hypnotics in elderly: a problem of drug dependence].
Topics: Aged; Aged, 80 and over; Anti-Anxiety Agents; Benzodiazepines; Diazepam; Female; Humans; Hypnotics and Sedatives; Mental Disorders; Middle Aged; Patient Admission; Psychometrics; Risk Factors; Substance Withdrawal Syndrome; Substance-Related Disorders | 2015 |
[Effect of GB-115 dipeptide on anxiety in rats with model benzodiazepine withdrawal syndrome].
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Animals, Outbred Strains; Anti-Anxiety Agents; Anxiety Disorders; Behavior, Animal; Benzodiazepines; Brain Chemistry; Diazepam; Dipeptides; Disease Models, Animal; Dopamine; Exploratory Behavior; Male; Maze Learning; Rats; Substance Withdrawal Syndrome; Tetragastrin; Tranquilizing Agents | 2011 |
[Role of GABA-ergic and dopaminergic mechanisms in the withdrawal syndrome after discontinuation of long-term phenazepam administration].
Topics: 5-Hydroxytryptophan; Animals; Anti-Anxiety Agents; Benzodiazepines; Benzodiazepinones; Brain; Dihydroxyphenylalanine; Disulfiram; Dopamine; gamma-Aminobutyric Acid; Humans; Male; Methyldopa; Rats; Semicarbazides; Substance Withdrawal Syndrome; Valproic Acid | 1980 |
[Effect of psychotropic drugs on sleep disorders in rats during alcohol withdrawal].
Topics: Alcoholism; Animals; Anti-Anxiety Agents; Apomorphine; Benzodiazepines; Benzodiazepinones; Haloperidol; Humans; Male; Psychotropic Drugs; Rats; Sleep Wake Disorders; Sodium Oxybate; Substance Withdrawal Syndrome | 1981 |
[Experimental study of the "'rebound syndrome" following discontinuation of prolonged phenazepam administration and possibilities for preventing it].
Topics: Animals; Anti-Anxiety Agents; Benzodiazepines; Benzodiazepinones; Chlorpromazine; Conditioning, Classical; Depression; Diazepam; Humans; Male; Meprobamate; Methaqualone; Morpholines; Phenobarbital; Rats; Substance Withdrawal Syndrome | 1981 |